UNSPSC 51285200: Dihydrofolate reductase inhibitor antibacterials

This classification denotes substances that inhibit dihydrofolate reductase, an enzyme which holds sway over cell division; these instant substances can, under certain circumstances, prevent cells from dividing and thus prevent spread of infection or even malignant cancer, substances that are therefore called dihydrofolate reductase inhibitors, this the term DIHYDROFOLATE REDUCTASE INHIBITOR ANTIBACTERIALS. This classification aims at the power of such substances to stay the proliferation of bacteria, which rely in part on dihydrofolate reductase to multiply.

UNSPSC 51285200 Dihydrofolate reductase inhibitor antibacterials is a Class code, but the recent state and local opportunities tagged under it show minimal alignment with the nominal scope. The three solicitations posted since January 2026 center on naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, medical and first aid supplies for emergency response, and generic multi-source pharmaceuticals and OTC products — none of which fall within dihydrofolate reductase inhibitor antibacterials. This mismatch suggests either systematic miscoding in the underlying procurement database or that the code is being applied as a catch-all for pharmaceutical and medical-supply procurement activity more broadly. Issuing bodies include county health departments (Seminole County, Florida), state health commissions (Texas HHS), municipal fire departments (City of Tampa), and multi-state cooperative purchasing alliances (Minnesota MMCAP), indicating that when pharmaceutical-adjacent work does appear under this code, it spans health authorities, emergency services, and cooperative purchasing vehicles.

Geographic activity centers on Florida, Texas, and Minnesota based on recent postings. Seminole County, Florida issued an IFB for naloxone and drug deactivation systems (IFB 60459723LAS, due July 26, 2023) requiring 1,900 units of naloxone and 800 deactivation systems annually with quarterly deliveries and a two-year initial term plus one-year renewal option. The City of Tampa released an ITB for medical and first aid supplies (26P00145, due March 13, 2026) valued at $700,000 for the Tampa Fire Department Rescue Division, with an SLBE set-aside and 5 percent bid discount not to exceed $10,000. Minnesota MMCAP issued an RFP for generic multi-source pharmaceuticals and OTC products (S1070000015802, due March 26, 2026) requiring vendors to work through three authorized wholesalers, with awards effective July 1, 2026. Texas HHS posted an RFI (HHS0017013, April 3, 2026) to gather vendor capabilities on direct-to-manufacturer prescription programs outside traditional PBM and GPO channels. The code does not show clear, recent, decision-relevant activity in its stated therapeutic category.